Article

GRF applauds donors

"The Glaucoma Research Foundation (GRF) ?applauded those who give? at its annual benefit and celebration Jan. 26. The theme of this year?s dinner, auction, and presentations was ?Applauding Those Who Give,? and the benefit focused on recent results from GRF-funded research and the donors who made it possible. "

San Francisco-The Glaucoma Research Foundation (GRF) “applauded those who give” at its annual benefit and celebration Jan. 26.

The theme of this year’s dinner, auction, and presentations was “Applauding Those Who Give,” and the benefit focused on recent results from GRF-funded research and the donors who made it possible.

“The annual benefit draws attention to the urgent need for research to cure glaucoma, a blinding disease affecting 70 million people worldwide, while paying tribute to all those who give in so many ways to help preserve vision,” said Thomas M. Brunner, the organization’s president and chief executive officer.

At the benefit, the GRF’s highest honor, the Catalyst Award, was presented to June Behrendt Otto, executive director of The Edward Joseph Daily Foundation. The award recognizes outstanding support for research and education to help those affected by glaucoma.

Also announced was the establishment of the Frank Stein and Paul S. May Grants for Innovative Glaucoma Research-a $100,000 gift that will substantially expand the GRF’s research grants program.

In addition, principal investigators in the “Catalyst For a Cure ” (CFC) consortium funded by the GRF updated attendees on their latest research results. CFC research attempts to foster a greater understanding of glaucoma as a degenerative nerve disease.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.